Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000466858 | SCV000547825 | uncertain significance | Fanconi anemia | 2022-09-13 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 471 of the FANCI protein (p.Pro471Arg). This variant is present in population databases (rs139072231, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FANCI-related conditions. ClinVar contains an entry for this variant (Variation ID: 408243). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FANCI protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000658083 | SCV000779854 | uncertain significance | not provided | 2018-05-18 | criteria provided, single submitter | clinical testing | The P471R variant in the FANCI gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The P471R variant is observed in 15/126,596 (0.01%) alleles from individuals of non-Finnish European background in large population cohorts (Lek et al., 2016). The P471R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. We interpret P471R as a variant of uncertain significance. |
Fulgent Genetics, |
RCV000763988 | SCV000894939 | uncertain significance | Fanconi anemia complementation group I | 2022-02-12 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV000658083 | SCV002011151 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing |